This intensive one-day course is intended to evaluate Good Distribution Practices (GDP)
as required by Directive 2001/83/EC, Directive 2004/27/EC, EU Guidelines on Good
Distribution of Medicinal Products for Human Use 94/C 63/03 and the new requirements
included in the 2007 Orange Guide. It offers a practical explanation of the guidelines for
those who are active in the field of setting up and implementing GDP, as well as the
management of quality systems for pharmaceutical products.
The course is aimed at any company that has obtained, or is considering obtaining an
MHRA Wholesale Dealer's Licence/EU Licence, Wholesalers/ Distributors, Manufacturers,
Pharmaceutical Suppliers and Service/Transport providers. It reviews GMP/GDP supply
chain integrity and examines the risk of counterfeit pharmaceutical products, a growing
concern today. The course also reviews sample deficiencies found by regulators and how
to improve compliance in these critical areas.
as required by Directive 2001/83/EC, Directive 2004/27/EC, EU Guidelines on Good
Distribution of Medicinal Products for Human Use 94/C 63/03 and the new requirements
included in the 2007 Orange Guide. It offers a practical explanation of the guidelines for
those who are active in the field of setting up and implementing GDP, as well as the
management of quality systems for pharmaceutical products.
The course is aimed at any company that has obtained, or is considering obtaining an
MHRA Wholesale Dealer's Licence/EU Licence, Wholesalers/ Distributors, Manufacturers,
Pharmaceutical Suppliers and Service/Transport providers. It reviews GMP/GDP supply
chain integrity and examines the risk of counterfeit pharmaceutical products, a growing
concern today. The course also reviews sample deficiencies found by regulators and how
to improve compliance in these critical areas.
